Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1133 | 2735 | 49.3 | 90% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1512 | 6953 | ONCOLYTIC VIRUS//VIROTHERAPY//CYTOSINE DEAMINASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ONCOLYTIC VIRUS | Author keyword | 318 | 73% | 9% | 246 |
2 | VIROTHERAPY | Author keyword | 158 | 65% | 5% | 150 |
3 | ONCOLYTIC ADENOVIRUS | Author keyword | 125 | 63% | 5% | 125 |
4 | ONCOLYTIC | Author keyword | 99 | 66% | 3% | 91 |
5 | ONCOLYSIS | Author keyword | 83 | 67% | 3% | 76 |
6 | ONCOLYTIC VIROTHERAPY | Author keyword | 79 | 74% | 2% | 59 |
7 | CANC GENE THER Y GRP | Address | 68 | 60% | 3% | 75 |
8 | G207 | Author keyword | 65 | 95% | 1% | 21 |
9 | SAN DIEGO SCI | Address | 48 | 63% | 2% | 48 |
10 | CONDITIONALLY REPLICATIVE ADENOVIRUS | Author keyword | 41 | 90% | 1% | 18 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ONCOLYTIC VIRUS | 318 | 73% | 9% | 246 | Search ONCOLYTIC+VIRUS | Search ONCOLYTIC+VIRUS |
2 | VIROTHERAPY | 158 | 65% | 5% | 150 | Search VIROTHERAPY | Search VIROTHERAPY |
3 | ONCOLYTIC ADENOVIRUS | 125 | 63% | 5% | 125 | Search ONCOLYTIC+ADENOVIRUS | Search ONCOLYTIC+ADENOVIRUS |
4 | ONCOLYTIC | 99 | 66% | 3% | 91 | Search ONCOLYTIC | Search ONCOLYTIC |
5 | ONCOLYSIS | 83 | 67% | 3% | 76 | Search ONCOLYSIS | Search ONCOLYSIS |
6 | ONCOLYTIC VIROTHERAPY | 79 | 74% | 2% | 59 | Search ONCOLYTIC+VIROTHERAPY | Search ONCOLYTIC+VIROTHERAPY |
7 | G207 | 65 | 95% | 1% | 21 | Search G207 | Search G207 |
8 | CONDITIONALLY REPLICATIVE ADENOVIRUS | 41 | 90% | 1% | 18 | Search CONDITIONALLY+REPLICATIVE+ADENOVIRUS | Search CONDITIONALLY+REPLICATIVE+ADENOVIRUS |
9 | ONCOLYTIC VIRAL THERAPY | 41 | 87% | 1% | 20 | Search ONCOLYTIC+VIRAL+THERAPY | Search ONCOLYTIC+VIRAL+THERAPY |
10 | ONCOLYTIC VIRUSES | 36 | 58% | 2% | 42 | Search ONCOLYTIC+VIRUSES | Search ONCOLYTIC+VIRUSES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ONYX 015 | 238 | 77% | 6% | 164 |
2 | VIROTHERAPY | 202 | 75% | 5% | 147 |
3 | COMPETENT ADENOVIRUS | 179 | 90% | 3% | 76 |
4 | VIRAL THERAPY | 126 | 85% | 2% | 67 |
5 | G207 | 121 | 97% | 1% | 34 |
6 | ATTENUATED ADENOVIRUS | 114 | 86% | 2% | 57 |
7 | ANTITUMORAL EFFICACY | 109 | 89% | 2% | 49 |
8 | ONCOLYTIC ADENOVIRUS | 89 | 48% | 5% | 137 |
9 | CONDITIONALLY REPLICATIVE ADENOVIRUS | 89 | 74% | 2% | 66 |
10 | REPLICATION SELECTIVE ADENOVIRUS | 78 | 60% | 3% | 85 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANCER GENE THERAPY | 29 | 12% | 8% | 223 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Oncolytic virotherapy | 2012 | 203 | 158 | 61% |
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress | 2007 | 216 | 44 | 89% |
New viruses for cancer therapy: meeting clinical needs | 2014 | 27 | 134 | 52% |
Going viral with cancer immunotherapy | 2014 | 21 | 120 | 58% |
Oncolytic viral therapies - the clinical experience | 2005 | 170 | 58 | 81% |
Recent progress in the battle between oncolytic viruses and tumours | 2005 | 296 | 117 | 49% |
Intelligent Design: Combination Therapy With Oncolytic Viruses | 2010 | 60 | 147 | 83% |
Viruses for Tumor Therapy | 2014 | 8 | 28 | 86% |
Oncolytic virus therapy for cancer: the first wave of translational clinical trials | 2013 | 19 | 77 | 81% |
Gene therapy progress and prospects cancer: oncolytic viruses | 2008 | 81 | 56 | 89% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC GENE THER Y GRP | 68 | 60% | 2.7% | 75 |
2 | SAN DIEGO SCI | 48 | 63% | 1.8% | 48 |
3 | FINNISH MOL MED | 24 | 53% | 1.1% | 31 |
4 | IMMUNOVIROTHER Y | 18 | 83% | 0.4% | 10 |
5 | REBECCA JOHN MOO COMPREHENS CANC | 16 | 45% | 1.0% | 27 |
6 | XINYUAN MED BIOTECHNOL | 15 | 34% | 1.4% | 37 |
7 | VIRAL VECTOR PROD | 15 | 88% | 0.3% | 7 |
8 | HUMAN GENE THER Y | 14 | 14% | 3.5% | 95 |
9 | GENE CELL THER Y | 14 | 31% | 1.3% | 36 |
10 | MOL NEUROSURG | 13 | 28% | 1.5% | 40 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000167753 | VIRAL ONCOLYSATE//CELLULAR IMMUNOL D010//MTH 68 H |
2 | 0.0000153066 | COXSACKIE ADENOVIRUS RECEPTOR//GENE TRANSFER REGULAT//COXSACKIE AND ADENOVIRUS RECEPTOR |
3 | 0.0000139620 | CYTOSINE DEAMINASE//SUICIDE GENE THERAPY//HERPES SIMPLEX VIRUS THYMIDINE KINASE |
4 | 0.0000082247 | GENETIC RADIOTHERAPY//GENE RADIOTHERAPY//PEDIAT MICROBIOL IMMUNOL RADIOL |
5 | 0.0000073957 | W ROXBURY VA HOSP//HERPES SIMPLEX VIRUS VECTOR//HELPER VIRUS FREE PACKAGING |
6 | 0.0000067214 | E1A//ADENOVIRUS E1A GENE//E4ORF6 |
7 | 0.0000064066 | TUMOR TROPISM//MOL NEUROTHER Y IMAGING//VET BIOCHEM IMMUNOL |
8 | 0.0000060426 | BIKDD//MITOCHONDRIAL CYTOCHROME C RELEASE//BAX OVEREXPRESSION |
9 | 0.0000056564 | MOL MED GENE THER Y UNIT//GUTLESS//HELPER DEPENDENT ADENOVIRUS |
10 | 0.0000049712 | SODIUM IODIDE SYMPORTER//SODIUM IODIDE SYMPORTER NIS//IODIDE TRANSPORT |